Open Access
J Oral Med Oral Surg
Volume 25, Number 4, 2019
Article Number 35
Number of page(s) 4
Section Cas clinique et revue de la littérature / Up-to date review and case report
Published online 17 September 2019
  1. Lombardi D, Bottazzoli M, Turri-Zanoni M, Raffetti E, Villaret AB, Morassi ML, et al. Sinonasal mucosal melanoma: A 12-year experience of 58 cases. Head Neck 2016;38 Suppl 1:E1737–E1745. [CrossRef] [PubMed] [Google Scholar]
  2. Williams MD. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Mucosal Melanomas. Head Neck Pathol 2017;11:110–117. [CrossRef] [PubMed] [Google Scholar]
  3. Ascierto PA, Accorona R, Botti G, Farina D, Fossati P, Gatta G, et al. Mucosal melanoma of the head and neck. Crit Rev Oncol Hematol 2017;112:136–152. [CrossRef] [PubMed] [Google Scholar]
  4. Gilain L, Houette A, Montalban A, Mom T, Saroul N. Mucosal melanoma of the nasal cavity and paranasal sinuses. Eur Ann Otorhinolaryngol Head Neck Dis 2014;131:365–369. [CrossRef] [PubMed] [Google Scholar]
  5. Papaspyrou G, Garbe C, Schadendorf D, Werner JA, Hauschild A, Egberts F. Mucosal melanomas of the head and neck: new aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitors. Melanoma Res 2011;21:475–482. [CrossRef] [PubMed] [Google Scholar]
  6. Guzzo M, Grandi C, Licitra L, Podrecca S, Cascinelli N, Molinari R. Mucosal malignant melanoma of head and neck: forty-eight cases treated at Istituto Nazionale Tumori of Milan. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 1993;19:316–319. [Google Scholar]
  7. Lee SP, Shimizu KT, Tran LM, Juillard G, Calcaterra TC. Mucosal melanoma of the head and neck: the impact of local control on survival. Laryngoscope 1994;104:121–126. [PubMed] [Google Scholar]
  8. Bradley PJ. Primary malignant mucosal melanoma of the head and neck. Curr Opin Otolaryngol Head Neck Surg 2006;14:100–104. [PubMed] [Google Scholar]
  9. Amit M, Tam S, Abdelmeguid AS, Kupferman ME, Su SY, Raza SM, et al. Patterns of treatment failure in patients with sinonasal mucosal melanoma. Ann Surg Oncol 2018;25:1723–1729. [CrossRef] [PubMed] [Google Scholar]
  10. Ribas A, Puzanov I, Dummer R, Schadendorf D, Hamid O, Robert C, et al. Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial. Lancet Oncol 2015;16:908–918. [CrossRef] [PubMed] [Google Scholar]
  11. Mignard C, Deschamps Huvier A, Gillibert A, Duval Modeste AB, Dutriaux C, Khammari A, et al. Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma. J Oncol 2018. [PubMed] [Google Scholar]
  12. Eisen D. Disorders of pigmentation in the oral cavity. Clin Dermatol 2000;18:579–587. [CrossRef] [PubMed] [Google Scholar]
  13. Hatch CL. Pigmented lesions of the oral cavity. Dent Clin North Am. 2005;49:185–201. [CrossRef] [PubMed] [Google Scholar]
  14. Meleti M, Leemans CR, Mooi WJ, van der Waal I. Oral malignant melanoma: the Amsterdam experience. J Oral Maxillofac Surg 2007;65:2181–2186. [CrossRef] [PubMed] [Google Scholar]
  15. Meleti M, Leemans CR, Mooi WJ, Vescovi P, van der Waal I. Oral malignant melanoma: a review of the literature. Oral Oncol 2007;43:116–121. [CrossRef] [PubMed] [Google Scholar]
  16. Gaeta GM, Satriano RA, Baroni A. Oral pigmented lesions. Clin Dermatol 2002;20:286–288. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.